Your browser version may not work well with NCBI's Web applications. More information here...
1: Nature. 2002 Jul 4;418(6893):41-9. Epub 2002 Jun 20.
Related Articles, Links
Click here to read
Erratum in:
  • Nature. 2007 Jun 14;447(7146):879-80.

Comment in:
Pluripotency of mesenchymal stem cells derived from adult marrow.

Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM.

Stem Cell Institute, University of Minnesota Medical School, Minneapolis, Minnesota 55455, USA.

We report here that cells co-purifying with mesenchymal stem cells--termed here multipotent adult progenitor cells or MAPCs--differentiate, at the single cell level, not only into mesenchymal cells, but also cells with visceral mesoderm, neuroectoderm and endoderm characteristics in vitro. When injected into an early blastocyst, single MAPCs contribute to most, if not all, somatic cell types. On transplantation into a non-irradiated host, MAPCs engraft and differentiate to the haematopoietic lineage, in addition to the epithelium of liver, lung and gut. Engraftment in the haematopoietic system as well as the gastrointestinal tract is increased when MAPCs are transplanted in a minimally irradiated host. As MAPCs proliferate extensively without obvious senescence or loss of differentiation potential, they may be an ideal cell source for therapy of inherited or degenerative diseases.

Publication Types:
PMID: 12077603 [PubMed - indexed for MEDLINE]